Actinium Pharmaceuticals shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Actinium Pharmaceuticals (ATNM) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Actinium Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Actinium Pharmaceuticals held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Actinium Pharmaceuticals by Bank of New York Mellon
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-06-30 | $639k | 86k | 7.40 |
2024-03-31 | $528k | 67k | 7.83 |
2023-12-31 | $583k | 115k | 5.08 |
2023-09-30 | $691k | 117k | 5.92 |
2023-06-30 | $852k | 115k | 7.42 |
2023-03-31 | $507k | 54k | 9.45 |
2022-12-31 | $629k | 59k | 10.65 |
2022-09-30 | $435k | 59k | 7.37 |
2022-06-30 | $245k | 51k | 4.82 |
2022-03-31 | $260k | 51k | 5.11 |
2021-12-31 | $305k | 51k | 6.00 |
2021-09-30 | $450k | 51k | 8.85 |
2021-06-30 | $402k | 51k | 7.91 |
2021-03-31 | $387k | 51k | 7.62 |
2020-12-31 | $434k | 56k | 7.80 |
2020-09-30 | $412k | 43k | 9.68 |